Patent Assignment
Reel/Frame 053300/0930
Merger
Recorded: 2020-07-24
Pages: 6
Assignor
SUPERGEN, INC.
Executed: 2011-09-09
Assignee
ASTEX PHARMACEUTICALS, INC.
4140 DUBLIN BOULEVARD, SUITE 200, DUBLIN, CALIFORNIA, 94568
Covered Properties
(6)
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
12/040,002 →
Publication:
US 2008/0214558
Axl Kinase Inhibitors
Axl Kinase Inhibitors
Application:
13/183,197 →
Publication:
US 2011/0269772
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/892,385 →
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/911,776 →
Axl Kinase Inhibitors
Application:
60/911,832 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019169/0031 →
Assignment of Assignor's Interest
Apr 25, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 019211/0413 →
Assignment of Assignor's Interest
Mar 13, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020648/0486 →
Assignment of Assignor's Interest
May 8, 2008
From: VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI; BEARSS, DAVID J.
To: SUPERGEN, INC.
Reel/Frame 020918/0017 →
Assignment of Assignor's Interest
Jul 29, 2008
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 021309/0536 →
Assignment of Assignor's Interest
Jul 26, 2012
From: ASTEX PHARMACEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 028650/0717 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Assignment of Assignor's Interest
Jul 22, 2020
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053279/0690 →
Assignment of Assignor's Interest
Jul 24, 2020
From: ASTEX PHARMACEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053301/0113 →
Change of Name
Jul 28, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053325/0735 →
Merger
Jul 28, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053325/0542 →